Education
About Us
Working with TipRanks
Follow Us
C-MER Eye Care Holdings Limited (HK:3309)
:3309
3309 Stock Chart & Stats
HK$1.70
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.70
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.33 - HK$2.16
Previous CloseN/A
Volume360.00K
Average Volume (3M)495.46K
Market Cap
HK$1.89B
Enterprise ValueHK$1.85B
Total Cash (Recent Filing)HK$435.71M
Total Debt (Recent Filing)HK$423.12M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.2%
Share Statistics
EPS (TTM)0.04
Shares Outstanding1,232,342,900
10 Day Avg. Volume419,185
30 Day Avg. Volume495,465
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.41
Price to Sales (P/S)1.30
P/FCF Ratio19.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.62
Revenue Forecast (FY)HK$19.13B
Bulls Say, Bears Say
Bulls Say
Strong Equity And Low LeverageA high equity ratio and conservative debt-to-equity provide durable financial flexibility for capital expenditures and equipment investment in eye-care facilities. This balance-sheet strength helps the company absorb cyclical downturns and pursue strategic partnerships without excessive leverage over the medium term.
Diversified Clinical Revenue StreamsMultiple revenue sources—surgical procedures, diagnostic services, product sales and institutional partnerships—reduce single-source dependency and stabilize cash inflows. Diversification across service types and payers supports resilient revenue generation and long-term demand for core clinical services.
Regional Scale And Clinical FootprintOperating multiple hospitals and clinics with a sizable staff gives C-MER scale advantages in specialist staffing, referral networks and technology adoption. This regional footprint supports brand recognition and recurring patient flow, aiding durable competitive position in ophthalmic care.
Bears Say
Cash Generation Collapse In 2024A sudden drop to zero operating and free cash flow materially impairs the firm's ability to self-fund capex, service obligations, and expand clinics. Sustained weak cash generation forces reliance on external financing, increasing risk to operational continuity and strategic investments.
Deteriorating Profitability And MarginsMargins turning negative and declining EBITDA suggest structural pressure from costs, pricing, or utilization. Persistent margin deterioration reduces reinvestment capacity into technology and specialties, undermining long-term competitiveness and the company’s ability to improve operating leverage.
Negative Return On EquityA negative ROE indicates shareholder capital is producing losses, signaling impaired profitability relative to equity. If sustained, this erodes book value, deters new equity investment and constrains the company’s ability to fund strategic initiatives and sustain long-term growth.
C-MER Eye Care Holdings Limited News
3309 FAQ
What was C-MER Eye Care Holdings Limited’s price range in the past 12 months?
C-MER Eye Care Holdings Limited lowest stock price was HK$1.33 and its highest was HK$2.16 in the past 12 months.
What is C-MER Eye Care Holdings Limited’s market cap?
C-MER Eye Care Holdings Limited’s market cap is HK$1.89B.
When is C-MER Eye Care Holdings Limited’s upcoming earnings report date?
C-MER Eye Care Holdings Limited’s upcoming earnings report date is Mar 31, 2026 which is in 58 days.
How were C-MER Eye Care Holdings Limited’s earnings last quarter?
C-MER Eye Care Holdings Limited released its earnings results on Aug 26, 2025. The company reported HK$0.041 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.041.
Is C-MER Eye Care Holdings Limited overvalued?
According to Wall Street analysts C-MER Eye Care Holdings Limited’s price is currently Overvalued.
Does C-MER Eye Care Holdings Limited pay dividends?
C-MER Eye Care Holdings Limited pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 1.2%. See more information on C-MER Eye Care Holdings Limited dividends here
What is C-MER Eye Care Holdings Limited’s EPS estimate?
C-MER Eye Care Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does C-MER Eye Care Holdings Limited have?
C-MER Eye Care Holdings Limited has 1,232,342,900 shares outstanding.
What happened to C-MER Eye Care Holdings Limited’s price movement after its last earnings report?
C-MER Eye Care Holdings Limited reported an EPS of HK$0.041 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.478%.
Which hedge fund is a major shareholder of C-MER Eye Care Holdings Limited?
Currently, no hedge funds are holding shares in HK:3309
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
C-MER Eye Care Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.66%
12-Months-Change
Fundamentals
Return on Equity
-6.41%
Trailing 12-Months
Asset Growth
-0.42%
Trailing 12-Months
Company Description
C-MER Eye Care Holdings Limited
C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. It operates through the Provision of Ophthalmic Services and the Sale of Vision Aid Products segments. The company was founded by Shun Chiu Lam on February 1, 2016 and is headquartered in Hong Kong.
Technical Analysis
Options Prices
Currently, No data available
---